Cargando…
Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
The perfusion of human tumour xenografts was manipulated by administration of diltiazem and pentoxifylline, and the extent that observed changes in tumour perfusion altered tumour radiosensitivity was determined. 2 tumour systems having intrinsically different types of hypoxia were studied. The resp...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363939/ https://www.ncbi.nlm.nih.gov/pubmed/11720448 http://dx.doi.org/10.1054/bjoc.2001.2123 |
_version_ | 1782153829658132480 |
---|---|
author | Bennewith, K L Durand, R E |
author_facet | Bennewith, K L Durand, R E |
author_sort | Bennewith, K L |
collection | PubMed |
description | The perfusion of human tumour xenografts was manipulated by administration of diltiazem and pentoxifylline, and the extent that observed changes in tumour perfusion altered tumour radiosensitivity was determined. 2 tumour systems having intrinsically different types of hypoxia were studied. The responses of SiHa tumours, which have essentially no transient hypoxia, were compared to the responses of WiDr tumours, which contain chronically and transiently hypoxic cells. We found that relatively modest increases in net tumour perfusion increased tumour cell radiosensitivity in WiDr tumours to a greater extent than in SiHa tumours. Moreover, redistribution of blood flow within WiDr tumours was observed on a micro-regional level that was largely independent of changes in net tumour perfusion. Through fluorescence-activated cell sorting coupled with an in vivo–in vitro cloning assay, increases in the radiosensitivity of WiDr tumour cells at intermediate levels of oxygenation were observed, consistent with the expectation that a redistribution of tumour blood flow had increased oxygen delivery to transiently hypoxic tumour cells. Our data therefore suggest that drug-induced changes in tumour micro-perfusion can alter the radiosensitivity of transiently hypoxic tumour cells, and that increasing the radiosensitivity of tumour cells at intermediate levels of oxygenation is therapeutically relevant. © 2001 Cancer Research Campaign http://www.bjcancer.com |
format | Text |
id | pubmed-2363939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23639392009-09-10 Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity Bennewith, K L Durand, R E Br J Cancer Regular Article The perfusion of human tumour xenografts was manipulated by administration of diltiazem and pentoxifylline, and the extent that observed changes in tumour perfusion altered tumour radiosensitivity was determined. 2 tumour systems having intrinsically different types of hypoxia were studied. The responses of SiHa tumours, which have essentially no transient hypoxia, were compared to the responses of WiDr tumours, which contain chronically and transiently hypoxic cells. We found that relatively modest increases in net tumour perfusion increased tumour cell radiosensitivity in WiDr tumours to a greater extent than in SiHa tumours. Moreover, redistribution of blood flow within WiDr tumours was observed on a micro-regional level that was largely independent of changes in net tumour perfusion. Through fluorescence-activated cell sorting coupled with an in vivo–in vitro cloning assay, increases in the radiosensitivity of WiDr tumour cells at intermediate levels of oxygenation were observed, consistent with the expectation that a redistribution of tumour blood flow had increased oxygen delivery to transiently hypoxic tumour cells. Our data therefore suggest that drug-induced changes in tumour micro-perfusion can alter the radiosensitivity of transiently hypoxic tumour cells, and that increasing the radiosensitivity of tumour cells at intermediate levels of oxygenation is therapeutically relevant. © 2001 Cancer Research Campaign http://www.bjcancer.com Nature Publishing Group 2001-11 /pmc/articles/PMC2363939/ /pubmed/11720448 http://dx.doi.org/10.1054/bjoc.2001.2123 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Bennewith, K L Durand, R E Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity |
title | Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity |
title_full | Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity |
title_fullStr | Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity |
title_full_unstemmed | Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity |
title_short | Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity |
title_sort | drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363939/ https://www.ncbi.nlm.nih.gov/pubmed/11720448 http://dx.doi.org/10.1054/bjoc.2001.2123 |
work_keys_str_mv | AT bennewithkl druginducedalterationsintumourperfusionyieldincreasesintumourcellradiosensitivity AT durandre druginducedalterationsintumourperfusionyieldincreasesintumourcellradiosensitivity |